在快速和缓慢进展的肌缩性侧面硬化症患者中,MiR206和423-3p的调节方式不同

Antonio Musarò1, Gabriella Dobrowolny1, Chiara Cambieri2

  • 1DAHFMO-Unit of Histology and Medical Embryology, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Via A. Scarpa 14, 00161, Rome, Italy.

PubMed
概括

某些微RNAs (miRs) 在快速或缓慢进展的肌缩侧面硬化症 (ALS) 患者中显示出不同的水平. MiR206和miR423-3p可以作为ALS进展的预后生物标志物.